Current Report Filing (8-k)
August 15 2016 - 9:22AM
Edgar (US Regulatory)
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): August
15, 2016
CHINA JO-JO DRUGSTORES, INC.
(Exact name of Registrant as specified in charter)
Nevada
|
|
001-34711
|
|
98-0557852
|
(State or other jurisdiction
of Incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer
Identification No.)
|
1st Floor, Yuzheng Plaza, No. 76, Yuhuangshan Road
Hangzhou, Zhejiang Province, People’s Republic
of China
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
+86 (571) 88077078
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)
☐
Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On August 15, 2016, China Jo-Jo
Drugstores, Inc. (the “Company”) issued a press release announcing certain financial results for the first quarter
ended June 30, 2016. A copy of the press release is attached hereto as Exhibit 99.1.
This information under this Item
2.02 and the Press Release attached to this Form 8-K as Exhibit 99.1 shall be deemed to be “furnished” and shall not
be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities under that section and shall not be deemed incorporated by reference in any
filing under the Exchange Act or the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following is filed as an exhibit to this report:
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release, dated August 15, 2016.
|
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
CHINA JO-JO DRUGSTORES, INC.
|
|
|
|
Date: August 15, 2016
|
By:
|
/s/ Lei Liu
|
|
Name:
|
Lei Liu
|
|
Title:
|
Chief Executive Officer
|
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Mar 2024 to Apr 2024
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Apr 2023 to Apr 2024